Recombinant DNA technology has fundamentally changed vaccine development by allowing for the production of "subunit" vaccines, which contain only a specific part of a pathogen (like a surface protein) rather than the whole virus or bacteria. This eliminates the risk of the vaccine causing the disease it is intended to prevent. The Hepatitis B vaccine was the first successful recombinant...